Efficacy of travoprost for the treatment of patients with glaucoma
Conclusion:
The findings of the present study will summarize the updated evidence of travoprost for patients with glaucoma.
PROSPERO registration number: PROSPERO CRD42019126956.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: China Health | Databases & Libraries | Glaucoma | Internal Medicine | Pain | Perfusion | Science | Study | Travatan